Leech fibrinolytic protein, preparation method and application thereof

A technology of fibrinolytic protein and leech, which is applied in the field of medicine and achieves the effect of great development and application prospects

Inactive Publication Date: 2014-09-03
SHANDONG UNIV
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there is no report on the separation and purification of a protein with a molecular weight of 20,000 to 30,000 with fibrinolytic activity from the broad-bodied leech by trypsin enzymatic hydrolysis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Leech fibrinolytic protein, preparation method and application thereof
  • Leech fibrinolytic protein, preparation method and application thereof
  • Leech fibrinolytic protein, preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0019] Embodiment 1 extracts leech fibrinolytic protein from dry leech

[0020] Proceed as follows:

[0021] (1) Weigh the dried leeches, pulverize them with a pulverizer, add 20 times of water and soak them for 48 hours at 4°C and then homogenize them. Add 1% trypsin and 5% crude enzyme of dry leeches to the homogenate for enzymolysis (pH8.2~8.5, temperature 50°C), after 5h, trypsin with 1% weight of dry leech was added to continue enzymolysis for 4h; after enzymolysis was completed, the temperature returned to room temperature, and absolute ethanol was added to the enzymolysis solution to 75% , left standing overnight (12 hours) at 4°C, suction filtered to obtain the supernatant, concentrated under reduced pressure (concentrated to one-tenth of the original volume) to obtain the crude leech protein extract;

[0022] (2) The above-mentioned leech fibrinolytic protein crude product extract is carried out QSephroseFastFlow ion-exchange column chromatography, with the NaCl solu...

Embodiment 2

[0024] Example 2 The dissolution of leech fibrinolytic protein to fibrin

[0025] Specific steps are as follows:

[0026] Preparation of fibrin plate: Weigh 125mg of agarose, add it to 23ml of normal saline, boil and swell and balance it in a water bath at 55°C to 60°C; add 14ul100U / ml thrombin and 2.2ml6mg / ml fibrinogen solution after balance , shake continuously until cloudy, pour it into a plate with a diameter of 8cm immediately after being cloudy, place it horizontally and fully solidify, place it at 4°C for 30min, and then punch holes.

[0027] Determination of fibrinolytic activity: add 10ul leech fibrinolytic protein solution (the leech fibrinolytic protein prepared in embodiment 1, the concentration of leech fibrinolytic protein solution is 0.87mg / ml) in the well, after 37 ℃ incubation 24h, to fibrin The dissolution situation was observed and measured. Fibrinolysis results such as image 3 shown by image 3 It can be seen that the crude extract of leech fibrinolyt...

Embodiment 3

[0028] Example 3 The effect of leech fibrinolytic protein on thrombus dissolution in model mice

[0029] Specific steps are as follows:

[0030] 40 Kunming mice (body weight 20±1.0 g) were randomly divided into 4 groups, 10 mice in each group, half male and half female, and cultured separately. The blank control group, the model control group, the leech fibrinolytic protein crude extract group, and the HAP-5-1 group were followed in turn.

[0031] Except for the blank control group, thrombus models were produced in the other three groups. Slightly anesthetize the mice with ether, sterilize the back with 70% ethanol, inject 10 mg / mL carrageenan solution subcutaneously in the back at a dose of 100 mg / kg, and place the mice in a room with a temperature lower than 18°C ​​after the injection is completed. Feed in the environment, and pay attention to the changes in the tail of the mice. A dark red thrombosis area appeared on the tip of the tail of the mice during 4-24 hours, and...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Molecular weightaaaaaaaaaa
Login to View More

Abstract

The invention discloses leech fibrinolytic protein prepared by employing the following preparation method: (1) extracting a leech fibrinolytic protein crude product; (2) performing QSephroseFastFlow ion exchange column chromatography on the above leech fibrinolytic protein crude product, performing linear elution by using a NaCl solution, collecting the eluate corresponding to a fifth elution peak, concentrating and drying, so as to obtain leech fibrinolytic crude protein; and (3) dissolving the above obtained leech fibrinolytic crude protein with distilled water, performing SephacrylS-200 gel filtering chromatography, eluting with distilled water, getting the eluate corresponding to a first elution peak, concentrating and drying, so as to obtain leech fibrinolytic protein. Through in-vitro fibrinolysis experiments and animal in-vivo thrombolysis experiments of leech fibrinolytic protein, results show that leech fibrinolytic protein disclosed by the invention has obvious dissolving effect on fibrin formed in a blood clotting process, and has dissolving effect on thrombus in a model mouse. The results indicate that leech fibrinolytic protein has great exploitation application prospect for preparing thrombolytic drugs.

Description

technical field [0001] The invention relates to leech fibrinolytic protein and its preparation method and application, belonging to the field of medicine. Background technique [0002] Thrombotic disease occurs mostly in the atrium, ventricles, arteries, veins and microvessels, and mainly harms the vascular system of the heart, brain and lungs, causing death or disability in adults. Traditional treatment strategies for thrombotic diseases mainly include surgery, anticoagulation and thrombolysis. Heparin, small molecule heparin, and Fawarin have been used in a large number of clinical applications to show good results, but their side effects have always been a problem for long-term clinical use. [0003] With the in-depth research on the application of traditional Chinese medicine in cardiovascular and cerebrovascular diseases, the research on single traditional Chinese medicine has also been paid attention to. Leech is a traditional Chinese medicine. Chinese medicine belie...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12P21/06C07K14/745C07K1/18C07K1/16A61K38/36A61P7/02
Inventor吉爱国宋淑亮王晓晨孙倩倩
OwnerSHANDONG UNIV